1 Gavazzi G & Krause KH (2002) Aging and infection. Lancet Infect Disease 2, 659–665.
2 Ben-Yasuda A & Weksler ME (1992) Immune senescence: mechanisms and clinical implications. Cancer Invest 10, 525–531.
3 Makinodan TS, James J, Inamizu T, et al. (1984) Immunologic basis for susceptibility to infection in aged. Gerontology 30, 279–289.
4 Goodwin JS (1995) Decreased immunity and increased morbidity in the elderly. Nutr Rev 53, S41–S46.
5 Gill HS, Rutherfurd KJ, Cross ML, et al. (2001) Enhancement of immunity in the elderly by dietary supplementation with the probiotics Bifidobacterium lactis HN019. Am J Clin Nutr 74, 833–839.
6 Sheih YH, Chang BL, Wang LH, et al. (2001) Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr 20, 149–156.
7 Nagao F, Nakayama M, Muto T, et al. (2000) Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci Biotechnol Biochem 64, 2706–2708.
8 Ebina T, Ogama N & Murata K (1995) Antitumor effects of Lactobacillus bulgaricus 878R. Biotherapy 9, 65–70.
9 Kitazawa H, Harata T, Uemura J, et al. (1998) Phosphate group requirement for mitogenic activation of lymphocytes by an extracellular phosphopolysaccharide from Lactobacillus delbrueckii ssp. bulgaricus. Int J Food Microbiol 40, 169–175.
10 Nishimura-Uemura J, Kitazawa H, Kawai Y, et al. (2003) Functional alternation of murine macrophage stimulated with extracellular polysaccharides from Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. Food Microbiol 20, 267–273.
11 Makino S, Ikegami S, Kano H, et al. (2006) Immunomodulatory effects of polysaccharides produced by Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. J Dairy Sci 89, 2873–2881.
12 Dubois M, Gilles KA, Hamilton JK, et al. (1956) Colorimetric method for determination of sugars and related substances. Anal Chem 28, 350–356.
13 Petitti DB (2000) Meta-analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine, 2nd ed. New York: Oxford University Press.
14 Cooper H and Hedges LV (editors) (1994) The Handbook of Research Synthesis. New York: Russell Sage Foundation.
15 Ogata K, An E, Shioi Y, et al. (2001) Association between natural killer cell activity and infection in immunologically normal elderly people. Clin Exp Immunol 124, 392–397.
16 Meydani SN & Ha WK (2000) Immunologic effects of yogurt. Am J Clin Nutr 71, 861–872.
17 Fukushima Y, Miyaguchi S, Yamano T, et al. (2007) Improvement of nutritional status and incidence of infection in hospitalised, enterally fed elderly by feeding of fermented milk containing probiotic Lactobacillus johnsonii La1 (NCC533). Br J Nutr 98, 969–977.
18 Guillemard E, Tondu F, Lacoin F, et al. (2010) Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomized controlled trial. Br J Nutr 103, 58–68.
19 de Vrese M, Winkler P, Rautenberg P, et al. (2005) Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr 24, 481–491.
20 Van de Water J, Keen CL & Gershwin ME (1999) The influence of chronic yogurt consumption on immunity. J Nutr 129, 1492S–1495S.
21 Guffee J, Fan W & Stein-Streilein J (1989) The role of natural killer cells in early defense to influenza virus infection by the intranasal route. In Natural Killer Cells and Host Defense, p. 124 [Ades EW and Lopez C, editors]. Basel, Switzerland: S. Karger.
22 Welsh RM & Vargas-Cortes M (1992) Natural killer cells in viral infection. In The Natural Immune System: The Natural Killer Cell, pp. 107–150 [Lewis CE and McGee JO, editors]. New York: Oxford University Press.
23 Gill HS, Rutherfurd KJ & Cross ML (2001) Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J Clin Immunol 21, 264–271.
24 Takeda K, Suzuki T, Shimada SI, et al. (2006) Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin Exp Immunol 146, 109–115.
25 Chandra RK (1997) Nutrition and the immune system: an introduction. Am J Clin Nutr 66, 460S–463S.
26 Tamura J, Kubota K, Murakami H, et al. (1999) Immunomodulation by vitamin B12, augmentation of CD8+ T lymphocytes and natural killer (NK) cell activity in vitamin B12-deficient patients by methyl-B12 treatment. Clin Exp Immunol 116, 28–32.
27 Sakane T, Takeda S, Kotani H, et al. (1982) Effects of methyl-B12 on the in vitro immune function of human T lymphocytes. J Clin Immunol 2, 101–109.
28 Tucker KL, Qiao N, Scott T, et al. (2005) High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr 82, 627–635.
29 Clarke R (2008) B-vitamins and prevention of dementia. Proc Nutr Soc 67, 75–81.
30 Vogiatzoglou A, Refsum H, Johnston C, et al. (2008) Vitamin B12 status and rate of brain volume loss in dwelling elderly. Neurology 71, 826–832.
31 Nelson RJ (2004) Seasonal immune function and sickness responses. Trends Immunol 25, 187–192.
32 Garcia-Maurino S, Gonzalez-Haba MG, Calvo JR, et al. (1997) Melatonin enhances IL-2, IL-6, and IFN-γ production by human circulating CD4+ cells. J Immunol 159, 574–581.
33 Karasek M & Reiter RJ (2002) Melatonin and aging. Neuroendocrinol Lett 23, S14–S16.
34 Karasek M (2004) Melatonin, human aging, and age-related disease. Exp Gerontol 39, 1723–1729.
35 Castle SC (2000) Clinical relevance of age-related immune dysfunction. Clin Infect Dis 31, 578–585.
36 Yoshikawa TT (1983) Geriatric infectious diseases: an emerging problem. J Am Geriatr Soc 31, 34–39.
37 Adolfsson O, Meydani SN & Russell RM (2004) Yogurt and gut function. Am J Clin Nutr 80, 245–256.